Table 1 Baseline characteristics of a nationwide database of hepatocellular carcinoma.
Variable | Value |
|---|---|
Sex | |
Male | 7413 (79.2) |
Female | 1943 (20.8) |
Unknown | 2 (0.0) |
Age (year)† | 60.0 ± 11.4 (18‒113) |
Enrollment year | |
2008‒2010 | 4149 (44.3) |
2011–2014 | 5209 (55.7) |
Pathological diagnosis | |
Yes, biopsy and/or surgery was performed | 2811 (30.0) |
No | 6547 (70.0) |
Smoking at the time of diagnosis | |
Smoker | 4213 (45.0) |
Non-smoker | 5049 (54.0) |
Unknown | 96 (0.1) |
Diabetes Mellitus | |
Yes | 2265 (24.2) |
No | 7005 (74.9) |
Unknown | 88 (0.9) |
Hepatitis B virus | |
Yes | 5750 (61.4) |
No | 3353 (35.8) |
Unknown | 255 (2.7) |
Hepatitis C virus | |
Yes | 1131 (12.1) |
No | 7671 (82.0) |
Unknown | 556 (5.9) |
Alcoholic liver cirrhosis | |
Yes | 3015 (32.2) |
No | 6172 (66.0) |
Unknown | 171 (1.8) |
Performance status | |
0 | 6581 (70.3) |
1 | 1238 (13.2) |
2 | 283 (3.0) |
3 | 135 (1.4) |
4 | 78 (0.8) |
Unknown | 1043 (11.1) |
Child–Pugh class | |
A | 6702 (71.6) |
B | 2087 (22.3) |
C | 501 (5.4) |
Unknown | 68 (0.7) |
Albumin-Bilirubin grade | |
Grade 1 | 3761 (40.2) |
Grade 2 | 4500 (48.1) |
Grade 3 | 1054 (11.3) |
Unknown | 43 (0.5) |
Model for End-stage liver disease score | |
0‒10 | 6564 (70.1) |
11‒20 | 2371 (25.3) |
21‒30 | 220 (2.4) |
> 31 | 41 (0.4) |
Unknown | 162 (1.7) |
Largest tumor size (cm) | |
≤ 2.0 | 2408 (25.7) |
2.1‒5.0 | 3291 (35.2) |
5.1‒10.0 | 1844 (19.7) |
> 10.0 | 1000 (10.7) |
Unknown | 815 (8.7) |
Tumor burden | |
TB1 | 1439 (15.4) |
TB2 | 3310 (35.4) |
TB3 | 803 (8.6) |
TB4 | 3773 (40.3) |
Unknown | 33 (0.4) |
Vascular invasion | |
Yes | 2427 (25.9) |
No | 6931 (74.1) |
Unknown | 0 (0.0) |
Extrahepatic spread | |
Yes | 1369 (14.6) |
No | 7989 (85.4) |
Unknown | 0 (0.0) |
BCLC stage | |
0 | 623 (6.7) |
A | 3628 (38.8) |
B | 1060 (11.3) |
C | 3387 (36.2) |
D | 660 (7.1) |
Unknown | 0 (0.0) |
Alpha feto-protein | |
< 200 ng/mL | 5626 (60.1) |
≥ 200 ng/mL | 3136 (33.5) |
Unknown | 596 (6.4) |
